コカルボキシラーゼ
|
|
ヒドロキシエチルチアミン塩酸塩標準品
|
高速液体クロマトグラフ用 |
チアミン塩酸塩
|
和光特級 |
フラビンアデニンジヌクレオチド二ナトリウムn水和物
|
|
リボフラビン標準品
|
高速液体クロマトグラフ用 |
四酪酸リボフラビン
|
生化学用 |
ニコチン酸
|
和光特級 |
(+)-パントテン酸カルシウム
|
和光特級 |
D(+)-パンテノール
販売終了
|
和光特級 |
パントテン酸ナトリウム
|
|
ピリドキサール塩酸塩標準品
|
ビタミン分析用 |
ピリドキサール塩酸塩, 99%
|
|
りん酸ピリドキサール一水和物
|
和光特級 |
ピリドキサミン二塩酸塩標準品
|
ビタミン分析用 |
ピリドキシン塩酸塩
|
和光特級 |
ピリドキシン塩酸塩標準品
|
ビタミン分析用 |
ピリドキシン塩酸塩 (Vitamin B6)
|
|
(+)-ビオチン
|
和光一級 |
シアノコバラミン
|
和光特級 |
ヒドロキソコバラミン酢酸塩
|
生化学用 |
メチルコバラミン
|
生化学用 |
L(+)-アスコルビン酸
|
試薬特級 |
L(+)-アスコルビン酸標準品
|
高速液体クロマトグラフ用 |
α-カロテン標準品
|
高速液体クロマトグラフ用 |
β-カロテン標準品
|
高速液体クロマトグラフ用 |
酢酸レチノール
|
ビタミン定量用 |
パルミチン酸レチノール標準液
販売終了
|
高速液体クロマトグラフ用 |
ビタミンAパルミタート, 油性
|
和光特級 |
カルシフェロール
|
和光特級 |
カルシトリオール
|
薬理研究用 |
コレカルシフェロール
|
和光特級 |
dl-トコール
|
|
(±)-α-トコフェロール
|
和光一級 |
DL-α-トコフェロール
|
|
ジャスモン酸メチル ((±)-α-トコフェロール 約100ppm)
|
生化学用 |
日本薬局方トコフェロール標準品
|
|
酢酸(±)-α-トコフェロール
|
和光一級 |
酢酸(±)-α-トコフェロール標準品
|
食品分析用 |
日本薬局方トコフェロール酢酸エステル標準品
|
|
ニコチン酸(±)-α-トコフェロール
|
生化学用 |
日本薬局方トコフェロールニコチン酸エステル標準品
|
|
日本薬局方トコフェロールコハク酸エステル標準品
|
|
ビタミンE定量用標準試薬
|
|
ビタミンK1
|
|
フィロキノン標準品(異性体混合物)
|
高速液体クロマトグラフ用 |
(±)-1,2-ジチオラン-3-吉草酸
|
和光特級 |
葉酸
|
和光特級 |
ピロロキノリンキノン二ナトリウム
|
生化学用 |
ユビキノン-10標準品
|
高速液体クロマトグラフ用 |
酢酸エルゴステロール
|
ビタミンE定量用 |
酸性ホスファターゼ
|
ビタミンB1・B2定量用 |
プロピオン酸エルゴステロール
|
ビタミンE定量用 |
ヘキサン
|
ビタミン定量用 |
活性ビタチェンジ
|
ビタミンB1定量用 |
Rotigotine Related Compound K (25 mg) (7,8-Dihydronaphthalen-1-ol)
|
|
Red Clover Aerial Parts Isoflavone Aglycones Dry Extract (500 mg)
|
|
Quazepam Related Compound A (30 mg) (7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one)
|
|
Quercetin (200 mg)
|
|
Quetiapine Fumarate (200 mg)
|
|
Quetiapine System Suitability (25 mg) (Mixture contains Quetiapine Fumarate and about 1% each of Quetiapine Related Compound B, Quetiapine Related Compound G and Quetiapine Desethoxy)
|
|
Quetiapine Related Compound B (15 mg) (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride)
|
|
Quetiapine Related Compound G (15 mg) (Dibenzo[b,f][1,4]thiazepin-11(10H)-one)
|
|
Quetiapine Related Compound H (15 mg) (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine 1-oxide)
|
|
Quinapril Hydrochloride (400 mg)
|
|
Quinapril Related Compound A (50 mg) (Ethyl [3S-[(2R*), 3a, 11ab]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate)
|
|
Quinapril Related Compound B (50 mg) (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])
|
|
Quinic Acid (200 mg) (Cyclohexanecarboxylic acid, 1,3,4,5-tetrahydroxy-, (-)-)
|
|
Quinidine Gluconate (200 mg)
|
|
Quinidine Sulfate (500 mg)
|
|
Quinine Hydrochloride Dihydrate (1 g)
|
|
Quinine Sulfate (500 mg)
|
|
Quininone (50 mg) (Cinchonan-9-one, 6'-methoxy-, (8alpha)-)
|
|
Rabeprazole Sodium (250 mg)
|
|
Rabeprazole Related Compound A (25 mg) (Disodium 1-benzimidazol-2-yl-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate)
|
|
Rabeprazole Related Compound B (15 mg) (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide)
|
|
Rabeprazole Related Compound C (25 mg) (1H-Benzimidazole-2-thiol)
|
|
Rabeprazole Related Compound D (25 mg) (2-({[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfonyl)benzimidazole)
|
|
Rabeprazole Related Compound E (25 mg) (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole)
|
|
Rabeprazole Related Compound F (15 mg) (2-{[(4-Chloro-3-methyl-2-pyridyl)methyl]sulfinyl}benzimidazole)
|
|
Racepinephrine Hydrochloride (100 mg)
|
|
Ractopamine Hydrochloride (200 mg)
|
|
Raloxifene Hydrochloride (200 mg)
|
|
Raloxifene Related Compound C (20 mg) (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate)
|
|
Raltegravir Related Compound E (20 mg) (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide)
|
|
Ramipril (125 mg)
|
|
Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(Methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid)
|
|
Ramipril Related Compound B (20 mg) ((2S,3aS,6aS)-1-{[(S)-1-Methoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid)
|
|
Ramipril Related Compound C (20 mg) ((2S,3aS,6aS)-1-{[(S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-yl]-L-alanyl}octahydrocyclopenta[b]pyrrole-2-carboxylic acid hydrochloride)
|
|
Ramipril Related Compound D (20 mg) (Ethyl (S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate)
|
|
Ranitidine Hydrochloride (200 mg)
|
|
Ranitidine Resolution Mixture (20 mg)
|
|
Ranitidine Related Compound A (50 mg) (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate)
|
|
Ranitidine Related Compound B (50 mg) (N,N'-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine)
|
|
Ranitidine Related Compound C (50 mg) (N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine)
|
|
Ranolazine (100 mg)
|
|
Ranolazine Related Compound A (50 mg) ((+/-)-2-[(2-methoxyphenoxy)methyl]oxirane)
|
|
Ranolazine Related Compound B (50 mg) (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate)
|
|
Ranolazine Related Compound C (50 mg) (N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide)
|
|
Ranolazine Related Compound D (50 mg) (2,2'-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)acetamide])
|
|
Raspberry Alcohol (50 mg) (4-(3-Hydroxybutyl)phenol)
|
|
Raspberry Ketone (100 mg) (4-(4-Hydroxyphenyl)butan-2-one)
|
|
Rauwolfia Serpentina (15 g)
|
|
Rebaudioside A (500 mg) (13-[(2-O-Beta-D-glucopyranosyl-3-O-Beta-D-glucopyranosyl-Beta-D-glucopyranosyl)oxy] kaur-16-en-18-oic acid Beta-D-glucopyranosyl ester)
|
|
Refined Bleached Shellac (1 g)
|
|
Regular Bleached Shellac (100 mg)
|
|
Repaglinide (200 mg)
|
|
Repaglinide Related Compound A (10 mg) ((S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate salt)
|
|
Repaglinide Related Compound B (50 mg) (3-Ethoxy-4-ethoxycarbonylphenylacetic acid)
|
|
Repaglinide Related Compound C (25 mg) ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid)
|
|
Repaglinide Related Compound E (20 mg) ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid)
|
|
Reserpine (200 mg)
|
|
Residual Solvent Class 1 - Benzene (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 1 - 1,2-Dichloroethane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 1 - 1,1-Dichloroethene (1.2 mL/ampule; 3 ampules)
|
|
残留溶媒クラス2A
|
|
残留溶媒クラス2B
|
|
残留溶媒クラス2C
|
|
Residual Solvent Class 2 - Acetonitrile (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Chlorobenzene (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Chloroform (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Cumene (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Cyclohexane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - 1,2-Dichloroethene (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Methylene Chloride (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Methylisobutylketone (3 x 1.2 mL)
|
|
Residual Solvent Class 2 - 1,2-Dimethoxyethane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - N,N-Dimethylacetamide (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - N,N-Dimethylformamide (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - 1,4-Dioxane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - 2-Ethoxyethanol (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Ethylene Glycol (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Formamide (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Hexane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Methanol (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - 2-Methoxyethanol (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Methylbutylketone (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Methylcyclohexane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - N-Methylpyrrolidone (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Nitromethane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Pyridine (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Sulfolane (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Tetrahydrofuran (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Tetralin (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Toluene (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Trichloroethylene (1.2 mL/ampule; 3 ampules)
|
|
Residual Solvent Class 2 - Xylenes (1.2 mL/ampule; 3 ampules)
|
|
Resorcinol (200 mg)
|
|
trans-Resveratrol (100 mg)
|
|
Retinyl Palmitate (4 x 50 mg)
|
|
Rhodiola Rosea Root and Rhizome Dry Extract (1 g)
|
|
Ribavirin (200 mg)
|
|
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid)
|
|
Ribavirin Related Compound D (15 mg) (1H-1,2,4-triazole-3-carboxamide)
|
|
Ribose (300 mg)
|
|
Rifabutin (50 mg)
|
|
Rifampin (300 mg)
|
|
Rifampin Quinone (25 mg) (1,4-dideoxy-1,4-dihydro-3-[[[4-methyl-1-piperazinyl]imino]methyl]-1,4-dioxo-rifamycin)
|
|
Riluzole (200 mg)
|
|
Riluzole Related Compound A (25 mg) (4-(Trifluoromethoxy)aniline)
|
|
Rimantadine Hydrochloride (300 mg)
|
|
Rimexolone (100 mg)
|
|
Risedronate Sodium (350 mg)
|
|
Risedronate Related Compound A (20 mg) ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate)
|
|
Risedronate Related Compound B (20 mg) ([3,6-Bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt)
|
|
Risedronate Related Compound C (20 mg) ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))
|
|
Risperidone (100 mg)
|
|
Risperidone System Suitability Mixture (10 mg)
|
|
Risperidone Related Compounds Mixture (25 mg)
|
|
Ritodrine Hydrochloride (200 mg)
|
|
Risperidone Related Compound G (25 mg) (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride)
|
|
Ritonavir (200 mg)
|
|
Rivastigmine Related Compound C (15 mg) ((S)-3-[1-(Dimethylamino)ethyl]phenol)
|
|
Ritonavir Related Compounds Mixture (50 mg)
|
|
Rivastigmine Related Compound D (50 mg) (3-Acetylphenyl ethyl(methyl)carbamate)
|
|
Rivastigmine (0.1 mL)
|
|
Rivastigmine Tartrate R-Isomer (20 mg) ((R)-3-[1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate, hydrogen tartrate)
|
|
Rivastigmine Tartrate (200 mg)
|
|
Rivastigmine Related Compound A (15 mg) ((+)-Di-(p-toluoyl)-D-tartaric acid)
|
|
Rivastigmine Related Compound B (15 mg) ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)
|
|
Rizatriptan Benzoate (200 mg)
|
|
Rizatriptan Benzoate System Suitability Mixture (15 mg)
|
|
Rocuronium Bromide (250 mg) (COLD SHIPMENT REQUIRED)
|
|
Rocuronium Peak Identification Mixture (25 mg) (rocuronium bromide spiked with rocuronium related compounds A, B, C, D, E, F, G, and H)
|
|
Rivastigmine Related Compound E (15 mg) ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride)
|
|
Rivastigmine Related Compound F (25 mg) (3-Vinylphenyl ethyl(methyl)carbamate)
|
|
Ropinirole Hydrochloride (200 mg)
|
|
Ropinirole Related Compound A (50 mg) (4-(2-hydroxyethyl)indolin-2-one)
|
|
Ropinirole Related Compound B (50 mg) (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride)
|
|
Ropivacaine (200 mg)
|
|
Ropivacaine Hydrochloride (200 mg)
|
|
Ropivacaine Related Compound A (25 mg) (2,6-dimethylaniline hydrochloride)
|
|
Ropivacaine Related Compound B (50 mg) ((R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate)
|
|
Rosavin (25 mg) ((2E)-3-Phenylprop-2-en-1-yl 6-O-alpha-l-arabinopyranosyl-Beta-D-glucopyranoside)
|
|
Rosiglitazone Maleate (200 mg)
|
|
Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione)
|
|
Rosmarinic Acid (25 mg)
|
|
Rosuvastatin Calcium (300 mg)
|
|
Rosuvastatin Related Compound A (25 mg) (Calcium (3R,5S,E)-7-{4-(4-fluorophenyl)-2-[(2-hydroxy-N,2-dimethylpropyl)sulfonamide]-6-isopropylpyrimidin-5-yl}-3,5-dihydroxyhept-6-enoate salt (1:2))
|
|
Rosuvastatin Related Compound B (25 mg)
|
|
Rosuvastatin Related Compound C (25 mg) (tert-Butyl 2-[(4R,6S)-6-{(E)-2-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]vinyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate)
|
|
Rosuvastatin Enantiomer (25 mg) (Calcium (3S,5R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate salt (1:2))
|
|
Rotigotine (50 mg) ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
|
|
Rotigotine Hydrochloride (300 mg) ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
|
|
Rotigotine Related Compound C (25 mg) ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
|
|
Rotigotine Related Compound G (25 mg) ((S)-6-{Bis[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
|
|
Roxarsone (200 mg)
|
|
Rufinamide (200 mg)
|
|
Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide)
|
|
Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate)
|
|
Rutin (100 mg)
|
|
Racemic Tamsulosin Hydrochloride (50 mg)
|
|
Racemethionine (200 mg)
|
|
Racemic Tiagabine Hydrochloride Mixture (25 mg) ((S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride)
|
|
Retinyl Acetate (Vitamin A) (5 ampules x 0.5 g)
|
|